See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Natural Disasters
Donald Trump
Democratic Party
US Politics
Republican Party
Elon Musk
Baseball
Basketball
Stock Markets
US Economy
Climate Change
Social Media
Published • loading... • Updated

Arcutis Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - Arcutis Biotherapeutics

Summary by Arcutis Biotherapeutics
WESTLAKE VILLAGE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) — Q4 2024 net product revenue for ZORYVE® (roflumilast) was $69.4 million, a 413% increase compared to Q4 of 2023 and a 55% increase compared to Q3 of 2024; driven by strong portfolio demand growth and including a non-recurring adjustment of $4.1 million due to a reduction in reserves for product returns Full Year 2024 net product revenue for ZORYVE was $166.5 million, an increase of 471%…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Arcutis BiotherapeuticsArcutis Biotherapeutics

Arcutis Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - Arcutis Biotherapeutics

WESTLAKE VILLAGE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) — Q4 2024 net product revenue for ZORYVE® (roflumilast) was $69.4 million, a 413% increase compared to Q4 of 2023 and a 55% increase compared to Q3 of 2024; driven by strong portfolio demand growth and including a non-recurring adjustment of $4.1 million due to a reduction in reserves for product returns Full Year 2024 net product revenue for ZORYVE was $166.5 million, an increase of 471%…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Arcutis Biotherapeutics broke the news in on Tuesday, February 25, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Westlake Village

Westlake Village

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
Search
BlindspotLocal